Filing Details

Accession Number:
0001127602-11-001670
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-01-14 16:23:11
Reporting Period:
2011-01-11
Filing Date:
2011-01-14
Accepted Time:
2011-01-14 16:23:11
Original Submission Date:
2011-01-13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242998 R Jay Lamarche C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-01-11 15,900 $5.50 560,003 No 4 S Direct
Common Stock Disposition 2011-01-11 700 $5.51 559,303 No 4 S Direct
Common Stock Disposition 2011-01-11 8,400 $5.52 550,903 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2010.
  2. This amendment corrects an error in the price of the Common Stock, as previously reported on Form 4 filed on January 13, 2011.